News
Leo Lens Pharma Appoints Dan Myers CEO
Accomplished Ophthalmic Executive to Lead Company in Its Next PhaseSAN DIEGO, CA, USA (BUSINESS WIRE April 15, 2020) – Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) is pleased to announce the appointment of Dan Myers as Chief Executive Officer. Prior to joining
Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma
Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice
Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards
FOR IMMEDIATE RELEASELeo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product AwardsUnique Drug Delivery Contact Lens Product is a Finalist in the Life Sciences & Healthtech CategorySAN DIEGO, CA, USA (NOVEMBER 11, 2019) – Today, Leo Lens Technology announced that its unique
Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology
Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology
Leo Lens Selected as Presenting Company at Octane MTIF 2018
Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to www.mtif2018.com.